Home/Filings/4/0001447028-25-000088
4//SEC Filing

Nguyen Tuan 4

Accession 0001447028-25-000088

CIK 0001447028other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 4:24 PM ET

Size

6.0 KB

Accession

0001447028-25-000088

Insider Transaction Report

Form 4
Period: 2025-03-31
Nguyen Tuan
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-03-31+750,000750,000 total
    Exercise: $3.50Exp: 2035-03-31Common Shares (750,000 underlying)
Footnotes (2)
  • [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.
  • [F2]This option vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.

Issuer

Arbutus Biopharma Corp

CIK 0001447028

Entity typeother

Related Parties

1
  • filerCIK 0002063445

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:24 PM ET
Size
6.0 KB